Evidence map›Paper›PMID 37342179›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2023

Increasing Kidney-Exchange Options Within the Existing Living Donor Pool With CIAT: A Pilot Implementation Study.

Marry de Klerk, Judith A Kal-van Gestel, Dave Roelen, Michiel G H Betjes, Annelies E de Weerd, Marlies E J Reinders, Jacqueline van de Wetering, Marcia M L Kho, Kristiaan Glorie, Joke I Roodnat

Open access · goldAbstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Novel Allocation Strategies Can Boost Kidney Exchange Programs: A Monte Carlo Simulation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Marry de KlerkErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Judith A Kal-van GestelErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Dave RoelenDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center (LUMC), Leiden, Netherlands.
Michiel G H BetjesErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Annelies E de WeerdErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Marlies E J ReindersErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Jacqueline van de WeteringErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Marcia M L KhoErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Kristiaan GlorieErasmus Q-Intelligence, Erasmus University Rotterdam, Rotterdam, Netherlands.
Joke I RoodnatErasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
Erasmus MC · NLDutch Blood Transfusion Society · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computerized integration of alternative transplantation programs (CIAT) is a kidney-exchange program that allows AB0- and/or HLA-incompatible allocation to difficult-to-match patients, thereby increasing their chances. Altruistic donors make this available for waiting list patients as well. Strict criteria were defined for selected highly-immunized (sHI) and long waiting (LW) candidates. For LW patients AB0i allocation was allowed. sHI patients were given priority and AB0i and/or CDC cross-match negative HLAi allocations were allowed. A local pilot was established between 2017 and 2022. CIAT results were assessed against all other transplant programs available. In the period studied there were 131 incompatible couples; CIAT transplanted the highest number of couples (35%), compared to the other programs. There were 55 sHI patients; CIAT transplanted as many sHI patients as the Acceptable Mismatch program (18%); Other programs contributed less. There were 69 LW patients; 53% received deceased donor transplantations, 20% were transplanted via CIAT. In total, 72 CIAT transplants were performed: 66 compatible, 5 AB0i and 1 both AB0i and HLAi. CIAT increased opportunities for difficult-to-match patients, not by increasing pool size, but through prioritization and allowing AB0i and "low risk" HLAi allocation. CIAT is a powerful addition to the limited number of programs available for difficult-to-match patients.

Indexed as

Kidney TransplantationTissue and Organ ProcurementHumansKidneyLiving DonorsAB0-desenzitisationcomputerised allocationhighly immunisedHLA-desenzitisation transplantationkidney-exchange

Identifiers

PMID37342179
PMCPMC10278123
OpenAlexW4379469992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.